Amelioration of quality of life and lung function of chronic obstructive pulmonary disease by pranic healing as adjuvant therapy
Jois Nagaraja Srikanth, Mysore Srinivasachar Ananthakrishna, Gurumurthy Parthasarathi, Sindaghatta Krishnarao Chaya, Rajendra Rajgopal, Mahadeva Renuka Devi, Lancy D’Souza, Devidas Holla Amrutha, Padukudru Anand Mahesh
Abstract
Aims
To study the effects of Pranic Healing (PH), as a complementary therapy to improve lung function, physiological condition and quality of life of Chronic Obstructive Pulmonary Disease (COPD) patients.
Methods
Randomised, double-blind, placebo-controlled, pilot study. 21 males with a mean age of 61.6 years and COPD stage II were randomly allocated to PH and control groups. The PH group received PH sessions thrice weekly during the study. The control group received Sham PH. Data was collected during baseline and four scheduled visits of the participants during six months. The primary outcome of the study was to access the reduction in COPD symptoms and to increase participation in physical and social activities by evaluating Spirometry, St George’s Respiratory Questionnaire (SGRQ), 6 Minute Walk Test (6MWT) and Hamilton Rating Scale for Depression (HRSD).
Results
Significant improvement for PH group in Forced Expiratory Volume in the first second (p=0.02), SGRQ domains of Activity (p=0.006), Impact (p=0.002), Total (p=0.000), and non-significant change in Symptom domain (p=0.44). PH group showed a positive tendency in 6 MWT and HRSD scores with insignificant difference between the groups. No serious adverse events occurred during the study.
Conclusion
PH as an adjunct to conventional treatment can improve lung function and quality of life of COPD subjects.
Full Text:
To study the effects of Pranic Healing (PH), as a complementary therapy to improve lung function, physiological condition and quality of life of Chronic Obstructive Pulmonary Disease (COPD) patients.
Methods
Randomised, double-blind, placebo-controlled, pilot study. 21 males with a mean age of 61.6 years and COPD stage II were randomly allocated to PH and control groups. The PH group received PH sessions thrice weekly during the study. The control group received Sham PH. Data was collected during baseline and four scheduled visits of the participants during six months. The primary outcome of the study was to access the reduction in COPD symptoms and to increase participation in physical and social activities by evaluating Spirometry, St George’s Respiratory Questionnaire (SGRQ), 6 Minute Walk Test (6MWT) and Hamilton Rating Scale for Depression (HRSD).
Results
Significant improvement for PH group in Forced Expiratory Volume in the first second (p=0.02), SGRQ domains of Activity (p=0.006), Impact (p=0.002), Total (p=0.000), and non-significant change in Symptom domain (p=0.44). PH group showed a positive tendency in 6 MWT and HRSD scores with insignificant difference between the groups. No serious adverse events occurred during the study.
Conclusion
PH as an adjunct to conventional treatment can improve lung function and quality of life of COPD subjects.
PDF